Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 26Unknown 7Recruiting 7Not yet recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Endocrine 1Breast 1

Conditions

Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Papillary Thyroid Microcarcinoma 1Breast Neoplasms 1

Interventions

Cisplatin 122Carboplatin 120Drug Therapy 104Bevacizumab 101Capecitabine 96Oxaliplatin 95Radiotherapy 92Gemcitabine 88Paclitaxel 87tislelizumab 84Cyclophosphamide 83Specimen Handling 80pembrolizumab 76toripalimab 66Magnetic Resonance Spectroscopy 63Fluorouracil 61sintilimab 58Injections 57anlotinib 51Docetaxel 51Surgical Procedures, Operative 48130-nm albumin-bound paclitaxel 48fludarabine 45Pemetrexed 43Standard of Care 42Biopsy 42venetoclax 41Irinotecan 41lenvatinib 40Leucovorin 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Decision Support Techniques × Clear all
NCT07497256 2026-04-30

BCT Aid

Xiamen University

Phase NA Not yet recruiting
160 enrolled
Breast

Breast Neoplasms

NCT07536412 2026-04-17

Decision Aid Efficacy in Low Risk Thyroid Cancer

University of Maryland, Baltimore

Phase NA Not yet recruiting
34 enrolled
EndocrineHead & Neck

Papillary Thyroid Microcarcinoma, Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡